Briefs – Sept. 29, 2008


CDISC awarded contract for training of FDA reviewers
The Clinical Data Interchange Standards Consortium (
CDISC), announced that the FDA has selected it, via a formal RFP process, to provide training to FDA reviewers of regulatory submissions. The courses to be taught over the next two years will include CDISC Basics, the CDISC Study Data Tabulation Model (SDTM), the CDISC Analysis Data Model (ADaM) and Advanced Topics on CDISC Standards. CDISC and its member partners for this training – Octagon Research Solutions, Destiny Corporation and Maximum Likelihood Solutions – will provide classroom as well as web-based virtual training for the requested courses.

Nextrials expands its executive team
Nextrials Inc. has added Robert Barr and Michelle Dockhorn to its executive staff. In his new position as chief technology officer, Barr will be responsible for the continued features and capabilities expansion of Prism, Nextrials’ flagship clinical trial management software and electronic data capture solution.  He is the former VP of software engineering for ClinPhone.  In the newly created position of VP of global sales and marketing, Dockhorn will direct Nextrials’ business initiatives and communications strategy. For more than 15 years, she has served in many operations, marketing and sales roles in the pharmaceutical industry, most recently as the VP of global sales and marketing at Focus Bio-Inova and IBT Laboratories. 

ACORN appoints Tara Webb senior director of CRO business development
Accelerated Community Oncology Research Network (
ACORN), a national oncology-focused contract research organization (CRO) and clinical trial network, has named Tara Webb as senior director of business development. Edward J. Stepanski, COO of ACORN, said in a press release: "[Webb’s] responsibilities at ACORN CRO will include presenting ACORN's capabilities to pharmaceutical companies and emerging biotechs, forging alliances with key accounts and providing customer service oversight on behalf of clients." Most recently, Webb served as senior director, business development, for i3 Statprobe, where she was responsible for developing new business opportunities and strengthening current client relationships both nationally and internationally.

Good Products and Adlib Software partner in pharmaceutical regulatory submissions
Good Products, a provider of enterprise content management solutions for the pharma, biotech and medical device industries, and Adlib Software, a producer of server-based document conversion, recognition and publishing software, announced an OEM partnership that aims to facilitate regulatory submissions in the pharmaceutical industry and will see the integration of Good Products' electronic document management system g-docs with Adlib Software's Express Server centralized PDF rendering tool. Using the new integrated system, pharmas will be able to store, manage and track regulatory documents and create high quality regulatory submission-ready PDFs with bookmarks and hyperlinks. Read the press release.

Paradigm Spine to implement PharmaPros’ automated trial management solution
Paradigm Spine, a provider of non-fusion and fusion spinal implant solutions, has entered an agreement with PharmaPros to implement the company’s automated trial management solution, Dataflow Manager, for its coflex IDE clinical study and future studies in its pipeline. The product will provide Paradigm Spine with one central interface through which to track and manage all of the clinical information for its study, including clinical data, safety data, medical images, site performance metrics, regulatory documents and reimbursement data.

---------------------

This story first appeared in eCliniqua,one of Bio-IT World’s free e-newsletters. Subscribe here.

 

solution

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.